Chemoinformaics analysis of 7-Methoxy-2-methylquinoline-5,8-dione
| Molecular Weight | 203.197 | nRot | 1 |
| Heavy Atom Molecular Weight | 194.125 | nRig | 13 |
| Exact Molecular Weight | 203.058 | nRing | 2 |
| Solubility: LogS | -2.755 | nHRing | 1 |
| Solubility: LogP | 1.144 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 27.8771 |
| nHD | 0 | BPOL | 13.6409 |
| QED | 0.69 |
| Synth | 2.472 |
| Natural Product Likeliness | 0.985 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.618 |
| MDCK | 0.0000244 |
| BBB | 0.482 |
| PPB | 0.906696 |
| VDSS | 0.499 |
| FU | 0.0250706 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.904 |
| CYP2c19-inh | 0.543 |
| CYP2c19-sub | 0.405 |
| CYP2c9-inh | 0.29 |
| CYP2c9-sub | 0.497 |
| CYP2d6-inh | 0.261 |
| CYP2d6-sub | 0.442 |
| CYP3a4-inh | 0.217 |
| CYP3a4-sub | 0.227 |
| CL | 6.667 |
| T12 | 0.626 |
| hERG | 0.019 |
| Ames | 0.951 |
| ROA | 0.869 |
| SkinSen | 0.853 |
| Carcinogencity | 0.862 |
| EI | 0.887 |
| Respiratory | 0.915 |
| NR-Aromatase | 0.235 |
| Antiviral | No |
| Prediction | 0.633852 |